Codes / ICD10CM / T38.813

T38.813 Poisoning by anterior pituitary [adenohypophyseal] hormones, assault

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by anterior pituitary [adenohypophyseal] hormones, assault

Summary

This condition refers to poisoning resulting from exposure to anterior pituitary hormones or their synthetic substitutes in an assault context. It applies when the specific hormone or agent is not identified, and the event is classified as assault. The code captures adverse effects or toxic reactions from these substances due to intentional harm by another party.

Causes

The causes involve intentional exposure to anterior pituitary hormones or synthetic substitutes as part of an assault. This may occur through forced ingestion, administration, or contact with substances containing these agents. Exposures can stem from deliberate harm by another individual, including the use of hormonal products to cause injury.

Risk Factors

  • Proximity to individuals with access to anterior pituitary hormone therapies or supplements
  • Situations involving conflict or violence where hormonal agents could be used
  • Lack of secure storage of hormonal products in environments prone to assault
  • Targeted harm involving substances with hormonal properties

Symptoms

Symptoms depend on the specific hormone involved but may include metabolic disturbances (e.g., hyper- or hypoglycemia), endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, with severity varying based on the dose and type of hormone.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of assault, and potential exposure to anterior pituitary hormones. Laboratory tests may assess hormone levels, metabolic status, or toxicology. Imaging or other studies could be used to evaluate organ function or injury. Documentation of the assault context is critical for accurate coding.

Treatment Options

Treatment focuses on managing acute symptoms, stabilizing the patient, and addressing any resulting complications. This may include supportive care, antidotes (if available), or interventions to counteract hormonal effects. Long-term management depends on the extent of exposure and organ involvement.

Prognosis and Follow-Up

Prognosis varies based on the dose, type of hormone, and timeliness of treatment. Follow-up may involve monitoring for delayed effects, endocrine function, or psychological support related to the assault. Recovery depends on the severity of poisoning and any underlying health conditions.

Complications

Complications can include persistent endocrine dysfunction, organ damage, or psychological trauma from the assault. Severe cases may lead to life-threatening metabolic or cardiovascular issues. Long-term effects depend on the specific hormone and extent of exposure.

Lifestyle & Prevention

Prevention involves secure storage of hormonal products and awareness of potential misuse in violent situations. Individuals at risk of assault should take precautions to limit access to such substances. Education on the dangers of hormonal poisoning may also reduce risk.

When to Seek Professional Help

Seek immediate medical attention if exposure to anterior pituitary hormones occurs in an assault context, especially with symptoms like severe metabolic changes, organ dysfunction, or signs of poisoning. Prompt care is essential to mitigate harm.

Tips for Medical Coders

Document the assault context clearly, as this distinguishes the code from other poisoning scenarios. Ensure the event is classified as intentional harm by another party, with no ambiguity about the cause. Verify that the code is used only when the specific hormone or agent is not identified, and the event is explicitly linked to assault.

Book a walkthrough

T38.813 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.